Variables | Controls (non-stroke) (n = 5,090) | Cases (stroke) (n = 509) | Crude OR (95% CI) | p-value | Adjusted ORa (95% CI) | p-value | |
---|---|---|---|---|---|---|---|
HZ | |||||||
No | 4,532 (89.04%) | 426 (83.69%) | Reference | Reference | |||
Yes | 558 (10.96%) | 83 (16.31%) | 1.58 (1.23–2.03) | < 0.001 | 1.85 (1.41–2.41) | < 0.001 | |
Sex | |||||||
Female | 419 (8.23%) | 46 (9.04%) | Reference | Reference | |||
Male | 4,671 (91.77%) | 463 (90.96%) | 0.90 (0.66–1.24) | 0.53 | 0.91 (0.65–1.27) | 0.59 | |
Age | |||||||
18–34 | 805 (15.82%) | 80 (15.72%) | Reference | Reference | |||
35–44 | 1,591 (31.26%) | 159 (31.24%) | 1.01 (0.76–1.33) | 0.96 | 0.76 (0.56–1.02) | 0.003 | |
45–54 | 1,644 (32.29%) | 160 (31.43%) | 0.98 (0.74–1.30) | 0.72 | 0.54 (0.39–0.73) | 0.45 | |
55–64 | 787 (15.46%) | 84 (16.50%) | 1.07 (0.78–1.48) | 0.56 | 0.44 (0.30–0.63) | 0.02 | |
≥ 65 | 263 (5.17%) | 26 (5.11%) | 0.99 (0.63–1.58) | 0.93 | 0.35 (0.21–0.58) | 0.007 | |
Geographic area | |||||||
North | 2,773 (54.48%) | 236 (46.37%) | Reference | Reference | |||
Central | 985 (19.35%) | 112 (22.00%) | 1.34 (1.05–1.69) | 0.04 | 0.92 (0.81–1.33) | 0.24 | |
South | 1,248 (24.52%) | 158 (31.04%) | 1.49 (1.20–1.84) | 0.007 | 1.24 (0.99–1.55) | 0.02 | |
East | 84 (1.65%) | 3 (0.59%) | 0.46 (0.13–1.34) | 0.06 | 0.38 (0.12–1.30) | 0.1 | |
Monthly income, USD | |||||||
< 660.50 | 2,368 (46.52%) | 333 (65.42%) | Reference | Reference | |||
660.50–1321.00 | 1,840 (36.15%) | 148 (29.08%) | 0.57 (0.47–0.70) | 0.16 | 0.56 (0.45–0.70) | 0.3 | |
> 1321.04 | 882 (17.33%) | 28 (5.50%) | 0.23 (0.15–0.33) | < 0.001 | 0.24 (0.16–0.36) | < 0.001 | |
Comorbidity | |||||||
Alcohol-related illness | |||||||
No | 5,012 (98.47%) | 494 (97.05%) | Reference | Reference | |||
Yes | 78 (1.53%) | 15 (2.95%) | 1.95 (1.11–3.42) | 0.02 | 1.30 (0.72–2.36) | 0.39 | |
Hypertension | |||||||
No | 3,752 (73.71%) | 236 (46.37%) | Reference | Reference | |||
Yes | 1,338 (26.29%) | 273 (53.63%) | 3.24 (2.70–3.90) | < 0.001 | 3.53 (2.86–4.34) | < 0.001 | |
Diabetes mellitus | |||||||
No | 4,798 (94.26%) | 469 (92.14%) | Reference | Reference | |||
Yes | 292 (5.74%) | 40 (7.86%) | 1.40 (0.99–1.98) | 0.05 | 0.72 (0.49–1.08) | 0.11 | |
Hyperlipidemia | |||||||
No | 3,899 (76.60%) | 357 (70.14%) | Reference | Reference | |||
Yes | 1,191 (23.40%) | 152 (29.86%) | 1.39 (1.14–1.70) | 0.001 | 1.41 (1.12–1.78) | 0.003 | |
PAOD | |||||||
No | 5,076 (99.72%) | 504 (99.02%) | Reference | Reference | |||
Yes | 14 (0.28%) | 5 (0.98%) | 3.60 (1.29–10.04) | 0.01 | 2.61 (0.83–8.17) | 0.1 | |
Coronary artery disease | |||||||
No | 4,996 (98.15%) | 494 (97.05%) | Reference | Reference | |||
Yes | 94 (1.85%) | 15 (2.95%) | 1.61 (0.93–2.80) | 0.09 | 1.12 (0.60–2.09) | 0.72 | |
Heart disease | |||||||
No | 5,626 (97.60%) | 468 (91.94%) | Reference | Reference | |||
Yes | 122 (2.40%) | 41 (8.06%) | 3.57 (2.47–5.15) | < 0.001 | 2.32 (1.54–3.48) | < 0.001 | |
Chronic kidney disease | |||||||
No | 4,957 (97.39%) | 476 (93.52%) | Reference | Reference | |||
Yes | 133 (2.61%) | 33 (6.48%) | 2.58 (1.75–3.83) | < 0.001 | 1.82 (1.16–2.85) | 0.01 | |
HBV | |||||||
No | 4,193 (82.38%) | 409 (80.35%) | Reference | Reference | |||
Yes | 897 (17.62%) | 100 (19.65%) | 1.14 (0.91–1.44) | 0.26 | 1.06 (0.83–1.36) | 0.63 | |
HCV | |||||||
No | 3,493 (68.62%) | 279 (54.81%) | Reference | Reference | |||
Yes | 1,597 (31.38%) | 230 (45.19%) | 1.80 (1.50–2.17) | < 0.001 | 1.49 (1.22–1.83) | < 0.001 | |
ART regimen | |||||||
Only NRTIs | |||||||
No | 4,212 (82.75%) | 421 (82.71%) | Reference | Reference | |||
Yes | 878 (17.25%) | 88 (17.29%) | 1.00 (0.79–1.28) | 0.98 | 0.99 (0.74–1.31) | 0.93 | |
Only NNRTIs | |||||||
No | 4,967 (97.97%) | 492 (96.66%) | Reference | Reference | |||
Yes | 123 (2.03%) | 17 (3.34%) | 1.40 (0.83–2.34) | 0.2 | 1.25 (0.68–2.29) | 0.47 | |
Only PIs | |||||||
No | 4,181 (82.14%) | 393 (77.21%) | Reference | Reference | |||
Yes | 889 (17.86%) | 116 (22.79) | 1.40 (1.12–1.74) | 0.003 | 1.33 (1.05–1.69) | 0.02 |